Ari Melnick

Ari Melnick, MD, is the Laurel Gebroe Family Professor of Hematology/Oncology and Professor of Immunology and Pharmacology at Weill Cornell Medicine. Dr. Melnick’s research interests include epigenetic mechanisms, biology, immunology and molecular targeting of B-cell lymphomas and acute leukemias. He developed novel therapies to correct aberrant transcriptional regulation and signaling that have led to early and late phase clinical trials and FDA approvals.  Dr. Melnick has authored more than 340 published manuscripts in journals such as Nature, Science, Cell, Cancer Discovery, etc. He was the 2016 ICML Bonadonna Lecturer and recipient of the 2020 Beutler Prize for Translational Reasearch from the American Society of Hematology.